Hospira`s Retacrit (darbepoetin alfa) Receives Suppl Approval in the U.S.
In a welcome respite from the persistent nationwide Adderall shortage, Teva seems to have gotten a handle on its supply.
Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine HCL
Hospira`s Biologic Nivestym (filgrastim-aafi) Receives Approval in the U.S.
After a year plagued by recalls, Pfizer’s sterile injectables unit Hospira seems no closer to righting the ship over its glass-contamination woes. What’s more, the company’s latest product pulls threaten to intensify the ongoing shortages of several critical hospital drugs.
Hospira, Inc. Issues A Voluntary Nationwide Recall For 4.2% Sodium Bicarbonate Injection, 8.4% Sodium Bicarbonate Injection, and Atropine Sulfate Injection Due to the Potential Presence of Glass Particulate Matter
Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Bleomycin for Injection, USP 15 Units Single Dose ONCO-TAIN™ Glass Fliptop Vial Due To The Potential For Presence of Glass Particulate Matter
Enforcement Report - Week of November 15, 2023
Hospira, Inc. Issues a Voluntary Nationwide Recall for 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP Due to the Potential for Presence of Glass Particulate Matter
Enforcement Report - Week of February 1, 2023